文献速递肝病消化道肿瘤与早癌

欧洲原发性肝癌的不平等现象:现状分析

Inequities in primary liver cancer in Europe: The state of play.
PubMed 文献 · J Hepatol · 2024-01-17

本文从健康的社会决定因素(SDoH)视角,总结欧洲经济区和英国原发性肝癌风险因素、发病率及健康结局的差异分布证据。弱势和边缘化人群社会经济与教育水平低,受肝癌风险因素影响最大,原因包括乙肝疫苗接种和病毒性肝炎筛查、减害及治疗的可及性差异。酒精相关肝病在教育程度低、就业不稳定、经济不稳定、移民和贫困人群中仍高度流行。欧洲各地成人脂肪性肝病、超重/肥胖和糖尿病的比例因地区、性别、社会经济和教育背景及超加工食品销售点密度而存在显著差异。已报告肝硬化死亡率的不平等,居住在社会经济弱势地区和教育水平较低的人群死亡率最高。关键人群获得原发性肝癌医疗保健不足受复杂医疗系统、污名化、歧视、低教育、语言障碍和害怕披露影响,导致肝癌诊疗路径不平等。未来需研究SDoH对欧洲国家肝癌发病和结局的不同交互影响,最终目标是制定循证多层次公共卫生干预措施,减少SDoH对特定人群肝癌不成比例负担的促成和持续影响。

要点

  • 弱势和边缘化人群社会经济与教育水平低,受肝癌风险因素影响最大
  • 乙肝疫苗接种、病毒性肝炎筛查、减害和治疗的可及性差异是原因之一
  • 肝硬化死亡率在社会经济弱势地区和教育水平较低人群中最高

核心结论

  • 弱势和边缘化人群受肝癌风险因素影响最大,肝癌诊疗路径存在不平等。
  • 未来需研究SDoH对欧洲国家肝癌发病和结局的不同交互影响。
  • 最终目标是制定循证多层次公共卫生干预措施,减少SDoH对特定人群肝癌不成比例负担的促成和持续影响。

研究设计与样本

  • 本文总结欧洲经济区和英国从SDoH视角关于肝癌风险因素、发病率和健康结局差异分布的现有证据。

主要发现

  • 弱势和边缘化人群社会经济与教育水平低,受肝癌风险因素影响最大。
  • 乙肝疫苗接种和病毒性肝炎筛查、减害及治疗的可及性存在差异。
  • 酒精相关肝病在教育程度低、就业不稳定、经济不稳定、移民和贫困人群中仍高度流行。
  • 欧洲各地成人脂肪性肝病、超重/肥胖和糖尿病比例因地区、性别、社会经济和教育背景及超加工食品销售点密度而存在显著差异。
  • 肝硬化死亡率在社会经济弱势地区和教育水平较低人群中最高。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 未来需研究SDoH对欧洲国家肝癌发病和结局的不同交互影响。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Given the increasing burden of liver cancer in Europe, it is crucial to investigate how social determinants of health (SDoH) affect liver cancer risk factors and access to care in order to improve health outcomes equitably. This paper summarises the available evidence on the differential distribution of liver cancer risk factors, incidence, and health outcomes in the European Economic Area and the United Kingdom from an SDoH perspective. Vulnerable and marginalised populations have low socio-economic and educational levels and are the most affected by liver cancer risk factors. Reasons for this include varied access to hepatitis B virus vaccination and limited access to viral hepatitis B and C screening, harm reduction, and treatment. Additionally, alcohol-related liver disease remains highly prevalent among individuals with low education, insecure employment, economic instability, migrants, and deprived populations. Moreover, significant variation exists across Europe in the proportion of adults with steatotic liver disease, overweight/obesity, and diabetes, based on geographical area, gender, socio-economic and educational background, and density of ultra-processed food outlets. Inequities in cirrhosis mortality rates have been reported, with the highest death rates among individuals living in socio-economically disadvantaged areas and those with lower educational levels. Furthermore, insufficient healthcare access for key populations with primary liver cancer is influenced by complex healthcare systems, stigmatisation, discrimination, low education, language barriers, and fear of disclosure. These challenges contribute to inequities in liver cancer care pathways. Future studies are needed to explore the different SDoH-interlinked effects on liver cancer incidence and outcomes in European countries. The ultimate goal is to develop evidence-based multilevel public health interventions that reduce the SDoH impact in precipitating and perpetuating the disproportionate burden of liver cancer in specific populations.

来源:J Hepatol,查看原文。版权归原作者所有。

引用

  1. Kondili LA, Lazarus JV, Jepsen P, et al. Inequities in primary liver cancer in Europe: The state of play. J Hepatol. 2024. PMID: 38237866. doi:10.1016/j.jhep.2023.12.031

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。